Loading...
Effects of Exenatide on Diabetes, Obesity, Cardiovascular Risk Factors, and Hepatic Biomarkers in Patients with Type 2 Diabetes
Obesity increases the risk of diabetes up to 90-fold and worsens hyperglycemia, hyperinsulinemia, insulin resistance, dyslipidemia, and nonalcoholic fatty liver disease. For patients with type 2 diabetes, weight loss can trigger improvements in all these conditions and decrease the need for glucose-...
Na minha lista:
Main Authors: | , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Diabetes Technology Society
2008
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2771486/ https://ncbi.nlm.nih.gov/pubmed/19885351 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|